Characterization of aliphatic, cyclic, and aromatic N-terminally "capped" His-D-Phe-Arg-Trp-NH2 tetrapeptides at the melanocortin receptors

被引:32
作者
Holder, JR [1 ]
Marques, FF [1 ]
Xiang, ZM [1 ]
Bauzo, RM [1 ]
Haskell-Luevano, C [1 ]
机构
[1] Univ Florida, Dept Med Chem, Gainesville, FL 32610 USA
关键词
obesity; G-protein-coupled receptor; metanocortin receptor; melanotropin;
D O I
10.1016/S0014-2999(03)01322-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The melanocortin system is implicated in multiple physiological pathways including pigmentation, inflammation, erectile function, feeding behavior, energy homeostasis, weight homeostasis, and exocrine gland function, just to list a few. The endogenous agonists for the melanocortin receptors include the gene transcripts derived from the proopiomelanocortin gene and include the core tetrapeptide His-Phe-Arg-Trp sequence postulated to be important for melanocortin receptor selectivity and stimulation. Posttranslational processing of the proopiomelanocortin derived agonists results in the N-terminal acetylation and C-terminal amidation of alpha-melanocyte stimulation hormone (alpha-MSH). In this study we generated 25 N-terminally "capped" tetrapeptides containing the core sequence X-His-D-Phe-Arg-Trp-NH2 and pharmacologically characterized them at the mouse melanocortin,MC1 receptor, melanocortin MC3 receptor, melanocortin MC4 receptor, and melanocortin MC5 receptor. The N-terminal "capping" groups consisted of linear, cyclic, or aromatic moieties and all resulted in full agonist activity at the melanocortin receptors examined in this study. Increasing aliphatic chain length increased potency of the tetrapeptide derivatives, with the addition of octanoyl capping group resulting in 70- to 110-fold increased tetrapeptide potency at the melanocortin MC1 receptor (EC50=0.4 nM), melanocortin MC3 receptor (EC50=4.0 nM), and melanocortin MC4 receptor (EC50=0.4 nM) while only enhancing potency at the melanocortin MC5 receptor (EC50 = 0. 8 nM) by 8-fold, compared to the tetrapeptide HiS-D-Phe-Arg-Trp-NH2. This octanoyl derivative surprisingly resulted in a 14-fold greater potency than alpha-MSH (EC50 = 5.4 nM) at the mouse melanocortin MC4 receptor implicated in feeding behavior and obesity. The 3,3,3-triphenylpropionyl derivative resulted in greater than 14 muM agonist potencies at the melanocortin MC1 receptor, melanocortin MC3 receptor, and melanocortin MC4 receptor and possessed a 140 nM agonist EC50 value at the melanocortin MC5 receptor. This 3,3,3-triphenylpropionyl-His-D-Phe-Arg-Trp-NH2 peptide is a 100-fold selective agonist for the melanocortin MC5 receptor, versus the other melanocortin receptors studied herein, and is the first melanocortin MC5 receptor selective tetrapeptide derivative reported to date with nanomolar potency. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:41 / 52
页数:12
相关论文
共 58 条
[1]   Melanocortins and the brain: from effects via receptors to drug targets [J].
Adan, RAH ;
Gispen, WH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 405 (1-3) :13-24
[2]   Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat [J].
Adan, RAH ;
Szklarczyk, AW ;
Oosterom, J ;
Brakkee, JH ;
Nijenhuis, WAJ ;
Schaaper, WMM ;
Meloen, RH ;
Gispen, WH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 378 (03) :249-258
[3]   DESIGN OF POTENT LINEAR ALPHA-MELANOTROPIN 4-10 ANALOGS MODIFIED IN POSITION-5 AND POSITION-10 [J].
ALOBEIDI, F ;
HRUBY, VJ ;
CASTRUCCI, AMD ;
HADLEY, ME .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (01) :174-179
[4]   POTENT AND PROLONGED ACTING CYCLIC LACTAM ANALOGS OF ALPHA-MELANOTROPIN - DESIGN BASED ON MOLECULAR-DYNAMICS [J].
ALOBEIDI, F ;
CASTRUCCI, AMD ;
HADLEY, ME ;
HRUBY, VJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (12) :2555-2561
[5]   SYNTHESIS AND BIOLOGICAL-ACTIVITIES OF FATTY-ACID CONJUGATES OF A CYCLIC LACTAM ALPHA-MELANOTROPIN [J].
ALOBEIDI, F ;
HRUBY, VJ ;
YAGHOUBI, N ;
MARWAN, MM ;
HADLEY, ME .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (01) :118-123
[6]  
ALOBEIDI F, 1990, INT J PEPT PROT RES, V35, P228
[7]   A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences [J].
Benoit, SC ;
Schwartz, MW ;
Lachey, JL ;
Hagan, MM ;
Rushing, PA ;
Blake, KA ;
Yagaloff, KA ;
Kurylko, G ;
Franco, L ;
Danhoo, W ;
Seeley, RJ .
JOURNAL OF NEUROSCIENCE, 2000, 20 (09) :3442-3448
[8]  
Butler A A, 2001, Trends Genet, V17, pS50, DOI 10.1016/S0168-9525(01)02481-7
[9]   A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse [J].
Butler, AA ;
Kesterson, RA ;
Khong, K ;
Cullen, MJ ;
Pelleymounter, MA ;
Dekoning, J ;
Baetscher, M ;
Cone, RD .
ENDOCRINOLOGY, 2000, 141 (09) :3518-3521
[10]   9-FLUORENYLMETHOXYCARBONYL AMINO-PROTECTING GROUP [J].
CARPINO, LA ;
HAN, GY .
JOURNAL OF ORGANIC CHEMISTRY, 1972, 37 (22) :3404-&